Skip to main content
. 2018 May 17;12(8):905–919. doi: 10.1093/ecco-jcc/jjy047

Figure 3.

Figure 3.

Time to first respiratory tract infection [A], upper respiratory tract infection [B], and lower respiratory tract infection [C]. Kaplan–Meier curves of the time to first respiratory tract infection, upper respiratory tract infection, or lower respiratory tract infection for the combined GEMINI 1 and 2 study vedolizumab 4-week and 8-week maintenance therapy safety populations. Lower respiratory tract infection includes the MedDRA high-level term ‘lower respiratory tract and lung infection’. VDZ, vedolizumab.